French High Growth Potential Companies

Valneva

Market Cap: €419.9m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Fill Up Media

Market Cap: €18.9m

Offers digital advertising services.

MedinCell

Market Cap: €994.5m

A clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.

Crossject Société Anonyme

Market Cap: €102.2m

Develops needle-free injection systems in France.

2CRSI

Market Cap: €1.1b

Develops, manufactures, and distributes end-to-end computing solutions in France and internationally.

Rising Stone

Market Cap: €118.1m

Operates as a developer and builder of luxury and ultra-luxury real estate property in France.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

Odiot

Market Cap: €7.4m

Engages in the manufacture and sale of pieces and cutlery in silver, gold, and precious metals.

Younited Financial

Market Cap: €355.3m

Provides consumer credit services in France, Italy, Spain, Portugal, and internationally.

Adocia

Market Cap: €80.8m

A clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity.

Fermentalg

Market Cap: €42.3m

Provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally.

DBV Technologies

Market Cap: €835.7m

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

La Française de l'Energie

Market Cap: €212.4m

Operates as a carbon-negative energy production company in France and internationally.

OSE Immunotherapeutics

Market Cap: €98.2m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Arcure

Market Cap: €16.4m

Develops artificial intelligence (AI) solutions for the autonomy of industrial machinery in France.

ATEME

Market Cap: €148.4m

Engages in the production and sales of electronic and computer devices and instruments in Europe, the Middle East, Africa, the United States, Canada, Latin America, and the Asia Pacific.

SPIE

Market Cap: €8.2b

Provides multi-technical services in the areas of energy and communications in France, Germany, the Netherlands, and internationally.

Icape Holding

Market Cap: €53.7m

Engages in the manufacture, distribution, and sale of printed circuit boards (PCBs) and customized technical parts worldwide.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

Altamir

Market Cap: €871.9m

Altamir SCA, formerly known as Altamir Amboise, is a private equity investment arm of Amboise SAS, specializing in both direct and fund of fund investments, small and mid-cap companies.

OVH Groupe

Market Cap: €2.3b

Provides public and private cloud, shared hosting, and dedicated server products and solutions worldwide.

Archos

Market Cap: €11.1m

Manufactures and sells consumer electronics in France.

Largo

Market Cap: €6.3m

Engages in the sale of refurbished digital equipment primarily smartphones, tablets, and laptops in France.

Genfit

Market Cap: €439.2m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

SEMCO Technologies Société anonyme

Market Cap: €533.9m

Designs, manufactures, and markets components for the manufacturing of semiconductor devices in France and internationally.

ABIVAX Société Anonyme

Market Cap: €6.8b

A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

Amoéba

Market Cap: €54.1m

Develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France.

S.M.A.I.O

Market Cap: €43.9m

Provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery.

STIF Société anonyme

Market Cap: €293.5m

Manufactures and sells components for the handling of bulk products in France.

WALLIX GROUP

Market Cap: €163.4m

WALLIX GROUP SA publishes and provides cybersecurity software solutions worldwide.

Logic Instrument

Market Cap: €19.7m

Manufactures and sells mobile computers for the defense and corporate sectors in France, Germany, and internationally.

Nanobiotix

Market Cap: €1.5b

Operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

Les Constructeurs du Bois

Market Cap: €10.3m

Designs and constructs timber buildings in France.

Eurazeo

Market Cap: €2.7b

A private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments.

Xilam Animation

Market Cap: €19.9m

An integrated animation studio, creates, produces, and distributes original programs for children and adults in France, rest of Europe, the Americas, Asia, and Africa.

Figeac Aero Société Anonyme

Market Cap: €459.6m

Manufactures, supplies, and sells equipment and sub-assemblers for aeronautics sector in France.